Walvax Biotechnology Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 1,349.755 million compared to CNY 573.455 million a year ago. Operating income was CNY 466.419 million compared to CNY 118.218 million a year ago. Net income was CNY 319.196 million compared to CNY 61.491 million a year ago. Basic earnings per share from continuing operations was CNY 0.2048 compared to CNY 0.04 a year ago. Diluted earnings per share from continuing operations was CNY 0.2016 compared to CNY 0.0395 a year ago.